Yujiro S Hata insider trades: IDEAYA Biosciences (IDYA) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Yujiro reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 6, 2026 | IDYA | ↓ Sell | 26,338 | $37.41 | $985K | Direct | Oct 8, 2026 (2d) |
| May 16, 2024 | IDYA | ↓ Sell | 175,000 | $42.27 | $7.4M | Direct | May 16, 2024 (0d) |
| Feb 9, 2024 | IDYA | ↓ Sell | 99,372 | $45.24 | $4.5M | Direct | Feb 12, 2024 (3d) |
| Feb 1, 2024 | IDYA | ↓ Sell | 628 | $45.00 | $28K | Direct | Feb 5, 2024 (4d) |
| Jan 16, 2024 | IDYA | ↓ Sell | 75,000 | $40.15 | $3.0M | Direct | Jan 17, 2024 (1d) |
| Dec 15, 2023 | IDYA | ↓ Sell | 75,000 | $35.03 | $2.6M | Direct | Dec 19, 2023 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other IDYA insiders
Open-market trades in the last 12 months
About Yujiro S Hata's insider trades
Yujiro S Hata is President and CEO at IDEAYA Biosciences (IDYA). Since Dec 15, 2023, Yujiro has reported no open-market purchases and 6 sales worth $18.5M on SEC Form 4. In the last 12 months: 1 sale ($985K).
Their filings also include grants and awards (20 filings), option exercises (11 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IDYA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.